Advertisement
Screener

USANA HEALTH SCIENCES, INC. (USNA) Payments to Noncontrolling Interests

2.8 / 5 stars · 68/120 Roast Me

USANA HEALTH SCIENCES, INC. Payments to Noncontrolling Interests

USANA HEALTH SCIENCES, INC. (USNA) reported Payments to Noncontrolling Interests of $0 for the 3-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:PaymentsToMinorityShareholders · last filed 2026-08-13

  • USANA HEALTH SCIENCES, INC. payments to noncontrolling interests for the quarter ending 2026-07-04 was $0.00, a 100.00% decline year-over-year.
  • USANA HEALTH SCIENCES, INC. payments to noncontrolling interests for the quarter ending 2026-04-04 was $1.38M.
  • USANA HEALTH SCIENCES, INC. payments to noncontrolling interests for the quarter ending 2026-01-03 was $491.00K.
  • USANA HEALTH SCIENCES, INC. payments to noncontrolling interests for the quarter ending 2025-09-27 was $879.00K.
  • USANA HEALTH SCIENCES, INC. payments to noncontrolling interests for fiscal 2026 was $1.75M.
  • USANA HEALTH SCIENCES, INC. payments to noncontrolling interests for fiscal 2024 was $0.00.
  • USANA HEALTH SCIENCES, INC. payments to noncontrolling interests for fiscal 2023 was $0.00.
Period endPayments to Noncontrolling Interests 3 monthPayments to Noncontrolling Interests 6 monthPayments to Noncontrolling Interests 9 monthPayments to Noncontrolling Interests 12 month
2026-07-04$0.00
10-Q · filed 2026-08-13
$1.38M
10-Q · filed 2026-08-13
$1.87M
derived: sum of 3 quarters · filed 2026-08-13
$2.75M
derived: sum of 4 quarters · filed 2026-08-13
2026-04-04$1.38M
10-Q · filed 2026-05-12
$1.87M
derived: sum of 2 quarters · filed 2026-05-12
$2.75M
derived: sum of 3 quarters · filed 2026-05-12
$3.13M
derived: sum of 4 quarters · filed 2026-08-13
2026-01-03$491.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$1.37M
derived: sum of 2 quarters · filed 2026-03-16
$1.75M
derived: sum of 3 quarters · filed 2026-08-13
$1.75M
10-K · filed 2026-03-16
2025-09-27$879.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$1.26M
derived: sum of 2 quarters · filed 2026-08-13
$1.26M
10-Q · filed 2025-11-05
$1.26M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-28$379.00K
10-Q · filed 2026-08-13
$379.00K
10-Q · filed 2026-08-13
$379.00K
derived: sum of 3 quarters · filed 2026-08-13
$379.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-29$0.00
10-Q · filed 2026-05-12
$0.00
derived: sum of 2 quarters · filed 2026-05-12
$0.00
derived: sum of 3 quarters · filed 2026-05-12
2024-12-28$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$0.00
derived: sum of 2 quarters · filed 2026-03-16
$0.00
10-K · filed 2026-03-16
2024-09-28$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$0.00
10-Q · filed 2025-11-05
2024-06-29$0.00
10-Q · filed 2025-08-05
2023-12-30$0.00
10-K · filed 2026-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Canopy Growth Corp (CGC)$0.395B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87